Su1816 COST-EFFECTIVENESS OF 5-ASA THERAPY IN COMBINATION WITH BIOLOGICS OR TOFACITINIB IN THE TREATMENT OF ULCERATIVE COLITIS
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI